| [1] |
Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun.
Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis
[J]. Clinical Focus, 2025, 40(4): 293-303.
|
| [2] |
Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin.
Value of T2WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients
[J]. Clinical Focus, 2025, 40(3): 251-256.
|
| [3] |
Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi.
Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis
[J]. Clinical Focus, 2025, 40(2): 143-146.
|
| [4] |
Zhang Shasha, Zhao Yingchun, Zhou Hongxia.
Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir
[J]. Clinical Focus, 2024, 39(11): 980-983.
|
| [5] |
Tang Aijun, Wang Liwei.
Predictive values of platelet count and coagulation index in the 28-day survival of sepsis patients
[J]. Clinical Focus, 2023, 38(3): 250-254.
|
| [6] |
Cheng Mingrong, Dai Dejian.
Efficacy of Zhenqi Fuzheng Capsule combined with ursodeoxycholic acid on primary biliary cholangitis and its impact on thyroid function
[J]. Clinical Focus, 2020, 35(3): 260-263.
|
| [7] |
Wang Yankun1， Ma Junji2, Zhang Ming2.
Role of cytokeratin 7 in pathological diagnosis of liver cirrhosis
[J]. Clinical Focus, 2019, 34(2): 124-127.
|
| [8] |
Huang Guangming, Gu Dahui, Hao Yaqin, He Zhijun.
Effect of nutritional status on clinical outcomes in elderly patients with hepatic cirrhosis
[J]. Clinical Focus, 2019, 34(2): 128-131.
|
| [9] |
Jin Yan, Ge Zhihua, Sun Yuanyuan, Xu Shuyan, Shao Jianguo.
Clinical study of AIMS65 score for risk assessment of esophagealgastric variceal bleeding in liver cirrhosis
[J]. Clinical Focus, 2018, 33(6): 498-501.
|
| [10] |
Zhao Wen， Zhang Siyu， Lu Yu， Zhao Suxian， Wang Rongqi， Nan Yuemin.
FibroTouch combined with FIB-4， APRI and GPRI in diagnosis of liver fibrosis
[J]. Clinical Focus, 2018, 33(2): 140-144.
|
| [11] |
Yang Xincheng, Jin Xiaoxu, Yao Jinfeng.
Research advances of portal vein thrombosis in liver cirrhosis
[J]. Clinical Focus, 2018, 33(11): 947-949，955.
|
| [12] |
Yin Kaige, Jin Xiaoxu, Feng Zhijie.
Endoscopic treatment of esophagogastric varices in cirrhosis
[J]. Clinical Focus, 2018, 33(11): 929-932.
|
| [13] |
Cheng Ran, Xu Xiaoyuan.
Diagnosis and therapy of ascites in liver cirrhosis
[J]. Clinical Focus, 2018, 33(11): 921-924.
|
| [14] |
Xu Manman1, Cheng Kailiang2, Qiu Qian3, Zhao Xinyu2, Duan Zhongping1, Wang Li2, Chen Yu1.
Factors associated with adherence to antiviral therapy in patients with HBV-related cirrhosis
[J]. Clinical Focus, 2018, 33(11): 950-955.
|
| [15] |
Kong Ming， Shi Hongbo， Bai Li， Yao Jia， Chen Yu， Duan Zhongping.
Characteristics of plasma amino acids in patients with HBVrelated chronic hepatitis， cirrhosis and acute on chronic liver failure
[J]. Clinical Focus, 2016, 31(7): 732-735,740.
|
